Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision updates from v3.6.5 to v3.6.6, indicating a small backend/content adjustment rather than a substantive change to study details or features.SummaryDifference0.0%

- Check18 days agoChange DetectedA new entry, '2016 ( U.S. NIH Grant/Contract )', was added to the list of study identifiers in the 'Other Study ID Numbers' section, indicating NIH funding for the trial.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now presents a full HTML error document indicating the content is temporarily unavailable, replacing the usual study record information on the page. This reflects a site-side issue rather than a content update.SummaryDifference15%

- Check47 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor release of the site’s page framework. This behind-the-scenes update does not change the visible study details or user-facing content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe term used to describe the liver condition on the page has been updated from Fatty Liver Disease to Steatotic Liver Disease. This reflects a glossary terminology update to align with current clinical language.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.2.SummaryDifference0.0%

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.